Fifteen years of putting patients before product lines
We are chemists, pharmacists, engineers and logisticians united by one measure of success: medicines that reach the people who need them.
From one suite to four facilities
- 2010
Founded in Boston
MED232 opens its first formulation suite with a team of nine.
- 2013
First GMP certification
Our oral solid dosage line passes full GMP inspection.
- 2016
Crossing borders
Distribution partnerships open in twelve new markets.
- 2019
Sterile injectables
A dedicated aseptic facility begins commercial production.
- 2022
Oncology suite
Contained cytotoxic manufacturing comes online.
- Today
30+ countries
120 products supporting more than ten million patients.
Mission, vision and values
Mission
To make dependable, affordable medicines available wherever they are needed — without ever compromising on quality.
Vision
A world where a patient's postcode never determines whether they receive the treatment they need.
Values
Scientific rigour, radical transparency, compassion for patients, and accountability in every batch we release.
The people accountable for every batch
A leadership team drawn from clinical research, regulatory affairs and global supply chain.
Dr. Elena Vargas
Chief Executive Officer
Dr. Samuel Adeyemi
Chief Scientific Officer
Mei-Lin Chen
VP, Quality Assurance
Jonas Berg
VP, Global Operations
Certifications & accreditations
Independently audited, continuously verified.